longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

INNOVENT BIO

01801

96.1502.18% ( +2.050 )
Delay Closed: Sep 17, 16:08:09
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 118.24, within the reasonable range, cheaper than 73.95% of the time in the past 1 years, and the industry ranks 21/78, the industry Median -5.54.

118.24xP/E
HK$96.15Stock price
HK$0.81Earnings per share
118.24xP/E
Stock priceHK$96.15Earnings per shareHK$0.81

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
129.47x
Typical range
116.93x–169.44x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0159318477636

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
01801HKINNOVENT BIO
118.24x191.08%HK$167.77B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.